Literature DB >> 12631681

To perform or not to perform liver biopsy: an alternative view.

D Joy, B B Scott.   

Abstract

Mesh：

Year:  2003        PMID： 12631681      PMCID： PMC1773598          DOI： 10.1136/gut.52.4.610

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology.

Authors:  A Grant; J Neuberger
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

2.  Pain experienced during percutaneous liver biopsy.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

3.  Letter: Nomogram for Bayes theorem.

Authors:  T J Fagan
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

4.  Ultrasound scanning in the detection of hepatic fibrosis and steatosis.

Authors:  S H Saverymuttu; A E Joseph; J D Maxwell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

5.  Prospective evaluation of the diagnostic accuracy of liver ultrasonography.

Authors:  J C Debongnie; C Pauls; M Fievez; E Wibin
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

6.  The accuracy of ultrasound in the detection of fatty infiltration of the liver.

Authors:  K J Foster; K C Dewbury; A H Griffith; R Wright
Journal:  Br J Radiol       Date:  1980-05       Impact factor: 3.039

7.  Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.

Authors:  M M Skelly; P D James; S D Ryder
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

8.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.

Authors:  I T Gilmore; A Burroughs; I M Murray-Lyon; R Williams; D Jenkins; A Hopkins
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

9.  The utility of radiological imaging in nonalcoholic fatty liver disease.

Authors:  Sherif Saadeh; Zobair M Younossi; Erick M Remer; Terry Gramlich; Janus P Ong; Maja Hurley; Kevin D Mullen; James N Cooper; Michael J Sheridan
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease.

Authors:  A E Joseph; S H Saverymuttu; S al-Sam; M G Cook; J D Maxwell
Journal:  Clin Radiol       Date:  1991-01       Impact factor: 2.350
  10 in total
  4 in total

Review 1.  Fibronectin: functional character and role in alcoholic liver disease.

Authors:  Razia S Aziz-Seible; Carol A Casey
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  To perform or not to perform liver biopsy: an alternative view.

Authors:  R W Chapman
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

3.  Validity of ultrasonography to assess hepatic steatosis compared to magnetic resonance spectroscopy as a criterion method in older adults.

Authors:  Emanuella De Lucia Rolfe; Soren Brage; Alison Sleigh; Francis Finucane; Simon J Griffin; Nick J Wareham; Ken K Ong; Nita G Forouhi
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

4.  Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease.

Authors:  Kathy Musa-Veloso; Carolina Venditti; Han Youl Lee; Maryse Darch; Seth Floyd; Spencer West; Ryan Simon
Journal:  Nutr Rev       Date:  2018-08-01       Impact factor: 7.110
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.